{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:33:34Z","timestamp":1785407614072,"version":"3.56.0"},"reference-count":22,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2026-1353"],"award-info":[{"award-number":["ORF-2026-1353"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"award":["ORF-2026-1353"],"award-info":[{"award-number":["ORF-2026-1353"]}],"id":[{"id":"https:\/\/ror.org\/02f81g417","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Transmitted drug resistance (TDR) remains a critical challenge in HIV-1 management, particularly in treatment-na\u00efve populations. Baseline genotypic resistance testing is recommended to optimize antiretroviral therapy (ART), yet data from Saudi Arabia remain limited. This study aimed to characterize HIV-1 genetic diversity and baseline resistance-associated mutations among newly diagnosed, ART-na\u00efve individuals. Methods: We conducted a multi-centre, retrospective cross-sectional study across three hospitals in Saudi Arabia between January 2023 and December 2024. Adult, treatment-na\u00efve patients with confirmed HIV infection who underwent genotyping using Sanger sequencing were included. Mutations in reverse transcriptase (RT), protease (PI), and integrase (INSTI) genes were analyzed using the Stanford HIV Drug Resistance Database. Demographic, clinical, and virological data were collected, and comparative analyses between regions were performed. Results: A total of 614 patients were included, predominantly male (85.5%) and aged 25\u201344 years. Most patients presented with high viral loads (\u226510,000 copies\/mL, 89.7%), and 25.3% had CD4 counts &lt;200 cells\/mm3. HIV-1 subtype distribution was highly diverse, with subtype C (19.5%), CRF02_AG (15.6%), and subtype G (12.7%) predominating. Although mutations were frequently detected (RT: 85.2%, PI: 94.7%, INSTI: 36.4%), the majority were subtype-associated polymorphisms rather than major drug resistance mutations. Clinically significant mutations including M184V\/I (1.17%), K103N (0.83%), and K65R (0.17%) were observed at low frequencies. No major INSTI resistance mutations were detected. Multi-class mutation patterns were common but largely driven by accessory variants. Conclusions: Despite the high prevalence of detected mutations, clinically significant TDR remained low, occurring in approximately 2.8% of patients. Most detected variants were polymorphic or accessory mutations, while susceptibility to INSTIs remained largely preserved. Continued baseline genotyping and molecular surveillance remain important to monitor emerging resistance patterns.<\/jats:p>","DOI":"10.3390\/v18080820","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:11:56Z","timestamp":1785168716000},"page":"820","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline HIV Genotyping and Antiretroviral Therapy Resistance Mutations in Saudi Arabian Population, a Multicentre, Cross-Sectional Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-0574","authenticated-orcid":false,"given":"Roa","family":"Al-Osaimi","sequence":"first","affiliation":[{"name":"Department of Adult Infectious Diseases, Jeddah First Health Cluster, East Jeddah General Hospital, Jeddah 22253, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-2097","authenticated-orcid":false,"given":"Moayad","family":"Al-Qurashi","sequence":"additional","affiliation":[{"name":"Division of Adult Infectious Diseases, Department of Medicine, King Fahad Armed Forces Hospital, Ministry of Defence\u2014Health Services, Jeddah 23311, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8663-6426","authenticated-orcid":false,"given":"Lama","family":"Al-Zamil","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batool","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Adult Infectious Diseases, Jeddah First Health Cluster, East Jeddah General Hospital, Jeddah 22253, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5752-9924","authenticated-orcid":false,"given":"Reem","family":"Al-Mutairy","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Fahad Armed Forces Hospital, Ministry of Defence\u2014Health Services, Jeddah 23311, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-960X","authenticated-orcid":false,"given":"Ali","family":"Al-Saeed","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Dammam Medical Complex of the Eastern Health Cluster, Dammam 32245, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meqbel","family":"Al-Shelawi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jeddah First Health Cluster, East Jeddah General Hospital, Jeddah 22253, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Khalaf","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dammam Medical Complex of the Eastern Health Cluster, Dammam 32245, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Subaie","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jeddah First Health Cluster, East Jeddah General Hospital, Jeddah 22253, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Faqih","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alexiev, I., and Dimitrova, R. (2025). The Origins and Genetic Diversity of HIV-1: Evolutionary Insights and Global Health Perspectives. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262210909"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dimitrov, D., Boily, M.-C., Brown, E.R., and Hallett, T.B. (2013). Analytic Review of Modeling Studies of ARV Based PrEP Interventions Reveals Strong Influence of Drug-Resistance Assumptions on the Population-Level Effectiveness. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080927"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/JVI.01556-08","article-title":"UK Collaborative Group on HIV Drug Resistance. Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating Among Treatment-Na\u00efve Individuals","volume":"83","author":"Gifford","year":"2009","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/QAD.0000000000000768","article-title":"A Phylotype-Based Analysis Highlights the Role of Drug-Naive HIV-Positive Individuals in the Transmission of Antiretroviral Resistance in the UK","volume":"29","author":"Mourad","year":"2015","journal-title":"AIDS"},{"key":"ref_5","first-page":"CD006495","article-title":"Antiretroviral Resistance Testing in HIV-Positive People","volume":"11","author":"Aves","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciz372","article-title":"Clinical Impact and Cost-Effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States","volume":"70","author":"Hyle","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.2024.24543","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society\u2013USA Panel","volume":"333","author":"Gandhi","year":"2025","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hiv.13446","article-title":"BHIVA Guidelines on Antiretroviral Treatment for Adults Living with HIV-1 2022","volume":"23","author":"Waters","year":"2022","journal-title":"HIV Med."},{"key":"ref_9","unstructured":"World Health Organization (2025). WHO Updated Recommendations on HIV Clinical Management: Recommendations for a Public Health Approach, World Health Organization."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/QAD.0000000000003192","article-title":"Baseline HIV Drug-Resistance Testing: 12 US Jurisdictions, 2014\u20132019","volume":"36","author":"Hugueley","year":"2022","journal-title":"AIDS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102859","DOI":"10.1016\/j.eclinm.2024.102859","article-title":"Global, Regional, and National Prevalence of HIV-1 Drug Resistance in Treatment-Naive and Treatment-Experienced Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"77","author":"Ge","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2217\/fvl-2018-0208","article-title":"Pretreatment Hiv Drug Resistance in Low- and Middle-Income Countries","volume":"14","author":"Inzaule","year":"2019","journal-title":"Future Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 Drug Resistance Before Initiation or Re-Initiation of First-Line Antiretroviral Therapy in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Regression Analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e23274","DOI":"10.1097\/MD.0000000000023274","article-title":"Genotyping and Antiretroviral Drug Resistance of Human Immunodeficiency Virus-1 in Jazan, Saudi Arabia","volume":"99","author":"Zaki","year":"2020","journal-title":"Medicine"},{"key":"ref_15","first-page":"CD006495","article-title":"Antiretroviral Resistance Testing in People Living with HIV","volume":"2017","author":"Tambe","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure: A Systematic Review and Pooled Analysis","volume":"305","author":"Li","year":"2011","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1089\/aid.2008.0101","article-title":"Identification of New CRF43_02G and CRF25_cpx in Saudi Arabia Based on Full Genome Sequence Analysis of Six HIV Type 1 Isolates","volume":"24","author":"Yamaguchi","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/aid.2007.0185","article-title":"Identification and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found","volume":"23","author":"Badreddine","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.antiviral.2007.03.006","article-title":"Molecular Basis of Antagonism Between K70E and K65R Tenofovir-Associated Mutations in HIV-1 Reverse Transcriptase","volume":"75","author":"Kagan","year":"2007","journal-title":"Antivir. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2217\/hiv.09.40","article-title":"The K65R Mutation in HIV-1 Reverse Transcriptase: Genetic Barriers, Resistance Profile and Clinical Implications","volume":"3","author":"Brenner","year":"2009","journal-title":"HIV Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Skhosana, L., Steegen, K., Bronze, M., Lukhwareni, A., Letsoalo, E., Papathanasopoulos, M.A., Carmona, S.C., and Stevens, W.S. (2015). High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118145"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/JVI.00056-10","article-title":"APOBEC3G Contributes to HIV-1 Variation Through Sublethal Mutagenesis","volume":"84","author":"Sadler","year":"2010","journal-title":"J. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/820\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:12:59Z","timestamp":1785168779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080820"],"URL":"https:\/\/doi.org\/10.3390\/v18080820","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]}}}